$ACOR
Acorda Therapeutics Inc
PRICE
$13.35 ▲15.086%
Extented Hours
VOLUME
23,950
DAY RANGE
11.6 - 12.7
52 WEEK
0.32 - 18.2
Key Metrics
Market Cap
15.54 M
Beta
0
Avg. Volume
8.15 K
Shares Outstanding
1.24 M
Yield
0%
Public Float
0
Next Earnings Date
2023-10-31
Next Dividend Date
Company Information
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
CEO: Ron Cohen
Website: http://www.acorda.com/
HQ: 420 Saw Mill River Rd Ardsley, 10502-2605 New York
Related News